News

A bunch of men have been talking about 'Ozempic penis' as a side-effect of the drug, but an expert has explained the truth ...
Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...
Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...
Danish investor Novo Holdings, the controlling shareholder of drugmaker Novo Nordisk, is evaluating buying a stake in ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 23, 2025 and would like to discuss your ...
Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.
The International Organization for Migration (IOM) has partnered with the Novo Nordisk Foundation, a Danish enterprise ...
It is especially memorable for UK savers investing in the world’s largest market: the S&P 500 is up in dollar terms but a slumping greenback means that it lost 3.6 per cent in sterling terms. The ...
Investing.com -- Novo Nordisk (NYSE: NVO) stock rose 1% after the company announced it has submitted an application to the ...
Fundsmith Equity Fund fell 1.9% in the first six months of the year, two percentage points less than what is perhaps the most ...
The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...